Health AI Central
Peer-Reviewed Publication
No Shinkei Geka2026;54(4):879-888.July 1, 2026Journal Article

[The Next Frontier of Medical AI in Brain Tumor Care:From Prediction to Trust].

Satoshi Takahashi1, Nobuji Kouno, Hirokazu Takami, Masamichi Takahashi, Ryuji Hamamoto
1AI Medical Engineering Team, RIKEN Center for Advanced Intelligence Project.
PubMed DOI

Abstract

Artificial intelligence (AI) is rapidly reshaping the diagnosis and treatment of malignant brain tumors. Within the molecularly defined 2021 World Health Organization (WHO) framework, deep learning now supports several tasks: noninvasive, rapid prediction of molecular alterations from MRI and intraoperative optical imaging (radiogenomics); integrated interpretation of histology and genomics for pr…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.